Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S)... | ResearchHub

Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

0

Authors

C. Westphalen

C. Westphalen•Diogo Martins-Branco•Vivek Subbiah

Published

August 1, 2024

Abstract

Advances in precision oncology led to approval of tumour-agnostic molecularly guided treatment options (MGTOs). The minimum requirements for claiming tumour-agnostic potential remain elusive.

Supporters

Support the authors with ResearchCoin

Journal

Annals of Oncology

Topics

Computer Science

Artificial Intelligence

Cancer Oncology

Medical Physics

DOI

10.1016/j.annonc.2024.07.730

License

Supporters

Support the authors with ResearchCoin

Journal

Annals of Oncology

Topics

Computer Science

Artificial Intelligence

Cancer Oncology

Medical Physics

DOI

10.1016/j.annonc.2024.07.730

License